Ashley Krystyna Bjelicic, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20300 Chagrin Blvd, Shaker Heights, OH 44122 Phone: 216-285-9667 |
Margaret Robenalt, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 18910 Oxford Rd, Shaker Heights, OH 44122 Phone: 216-991-6648 |
Thirumalai Sundara-rajan, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 22175 Rye Rd, Shaker Heights, OH 44122 Phone: 216-295-0047 |
Mr. Albert A Etheart, PA C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20300 Chargrin Blvd, Shaker Heights, OH 44122 Phone: 614-505-7633 |
Habtom Yebio Asghede, Physician Assistant Medicare: Medicare Enrolled Practice Location: 3429 Lee Rd Apt 4, Shaker Heights, OH 44120 Phone: 206-313-5501 |
News Archive
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has been awarded a contract for $2.5 million from the U.S. Department of Defense (DOD) to support the continuing development of monoclonal antibody (mAb) therapies against staphylococcal-derived toxins and pathogenic staphylococcal strains.
The human body contains trillions of cells, all derived from a single cell, or zygote, made by the fusion of an egg and a sperm. That single cell contains all the genetic information needed to develop into a human, and passes identical copies of that information to each new cell as it divides into the many diverse types of cells that make up a complex organism like a human being.
The National Institutes of Health has awarded six grants totaling approximately $12 million over three years through a new initiative aimed at fostering a diverse scientific workforce. The initiative, called the NIH Director's ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce, is funded through the American Recovery and Reinvestment Act (ARRA) and administered by NIH's National Institute of General Medical Sciences.
The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been subjected to the rigorous Food and Drug Administration's (FDA) review and approval process.
› Verified 8 days ago